Re: Long-term control in a patient with metastatic lung adenocarcinoma after discontinuation of nivolumab

J Oncol Pharm Pract. 2021 Jun;27(4):1052. doi: 10.1177/10781552211004680. Epub 2021 Mar 27.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenocarcinoma of Lung* / drug therapy
  • Humans
  • Lung Neoplasms* / drug therapy
  • Nivolumab / therapeutic use

Substances

  • Nivolumab